Phio Pharmaceuticals Corp.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2016 | $-7.8M | $-7.8M | $4.0K | $756.0K |
| FY2017 | $-9.5M | $-9.7M | $203.0K | $314.0K |
| FY2018 | $-7.5M | $-7.5M | $5.0K | $282.0K |
| FY2019 | $-8.6M | $-8.7M | $72.0K | $300.0K |
| FY2020 | $-8.8M | $-8.8M | $19.0K | $136.0K |
| FY2021 | $-11.9M | $-11.9M | $51.0K | $480.0K |
| FY2022 | $-12.1M | $-12.3M | $121.0K | $414.0K |
| FY2023 | $-10.7M | $-10.8M | $5.0K | $303.0K |
| FY2024 | $-7.1M | $-7.1M | $1.0K | $147.0K |
| FY2025 | $-8.0M | $-8.0M | $12.0K | $481.0K |